메뉴 건너뛰기




Volumn 5, Issue 6, 2010, Pages 741-761

Antiphospholipid syndrome in pregnancy

Author keywords

2 glycoprotein I; anticardiolipin antibodies; anticoagulation; antiphospholipid antibodies; antiphospholipid syndrome; lupus anticoagulant; pregnancy; recurrent fetal loss; teratogenicity; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BETA2 GLYCOPROTEIN 1 ANTIBODY; CYCLOPHOSPHAMIDE; DALTEPARIN; FONDAPARINUX; GLUCOCORTICOID; HEPARIN; HIRUDIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LIPOCORTIN 5; LOW MOLECULAR WEIGHT HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPID ANTIBODY; PLACEBO; PREDNISONE; RITUXIMAB; THROMBIN; WARFARIN;

EID: 78249245452     PISSN: 17474108     EISSN: None     Source Type: Journal    
DOI: 10.1586/eog.10.57     Document Type: Review
Times cited : (9)

References (139)
  • 1
    • 77953720577 scopus 로고    scopus 로고
    • Enrolling pregnant women in research - Lessons from the H1N1 influenza pandemic
    • Goldkind SF, Sahin L, Gallauresi B. Enrolling pregnant women in research - lessons from the H1N1 influenza pandemic. N. Engl. J. Med. 362(24), 2241-2243 (2010).
    • (2010) N. Engl. J. Med. , vol.362 , Issue.24 , pp. 2241-2243
    • Goldkind, S.F.1    Sahin, L.2    Gallauresi, B.3
  • 2
    • 0025075078 scopus 로고
    • Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population
    • Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust. N. Z. J. Med. 20(3), 231-236 (1990).
    • (1990) Aust. N. Z. J. Med. , vol.20 , Issue.3 , pp. 231-236
    • Shi, W.1    Krilis, S.A.2    Chong, B.H.3    Gordon, S.4    Chesterman, C.N.5
  • 3
    • 0027930963 scopus 로고
    • Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects
    • Vila P, Hernandez MC, Lopez-Fernandez MF, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb. Haemost. 72(2), 209-213 (1994).
    • (1994) Thromb. Haemost. , vol.72 , Issue.2 , pp. 209-213
    • Vila, P.1    Hernandez, M.C.2    Lopez-Fernandez, M.F.3    Batlle, J.4
  • 4
    • 33644606069 scopus 로고    scopus 로고
    • Management of antiphospholipid antibody syndrome: A systematic review
    • • Excellent review of antiphospholipid syndrome APS in the nonpregnant state
    • Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295(9), 1050-1057 (2006). • Excellent review of antiphospholipid syndrome (APS) in the nonpregnant state.
    • (2006) JAMA , vol.295 , Issue.9 , pp. 1050-1057
    • Lim, W.1    Crowther, M.A.2    Eikelboom, J.W.3
  • 5
    • 0028822703 scopus 로고
    • Antiphospholipid antibodies and venous thromboembolism
    • Ginsberg JS, Wells PS, Brill-Edwards P et al. Antiphospholipid antibodies and venous thromboembolism. Blood 86(10), 3685-3691 (1995).
    • (1995) Blood , vol.86 , Issue.10 , pp. 3685-3691
    • Ginsberg, J.S.1    Wells, P.S.2    Brill-Edwards, P.3
  • 6
    • 0030951829 scopus 로고    scopus 로고
    • Laboratory evaluation and clinical characteristics of 2, 132 consecutive unselected patients with venous thromboembolism - Results of the Spanish multicentric study on thrombophilia (EMET-Study)
    • Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2, 132 consecutive unselected patients with venous thromboembolism - results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb. Haemost. 77(3), 444-451 (1997).
    • (1997) Thromb. Haemost. , vol.77 , Issue.3 , pp. 444-451
    • Mateo, J.1    Oliver, A.2    Borrell, M.3    Sala, N.4    Fontcuberta, J.5
  • 7
    • 0036881080 scopus 로고    scopus 로고
    • Antiphospholipid antibodies
    • Triplett DA. Antiphospholipid antibodies. Arch. Pathol. Lab. Med. 126(11), 1424-1429 (2002).
    • (2002) Arch. Pathol. Lab. Med. , vol.126 , Issue.11 , pp. 1424-1429
    • Triplett, D.A.1
  • 8
    • 53049099468 scopus 로고    scopus 로고
    • Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: A potpourri of problems, a compilation of possible solutions
    • Favaloro EJ, Wong RC. Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solutions. Semin. Thromb. Hemost. 34(4), 389-410 (2008).
    • (2008) Semin. Thromb. Hemost. , vol.34 , Issue.4 , pp. 389-410
    • Favaloro, E.J.1    Wong, R.C.2
  • 9
    • 0036196287 scopus 로고    scopus 로고
    • Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome
    • Blank M, Krause I, Fridkin M et al. Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 109(6), 797-804 (2002).
    • (2002) J. Clin. Invest. , vol.109 , Issue.6 , pp. 797-804
    • Blank, M.1    Krause, I.2    Fridkin, M.3
  • 10
    • 0037216763 scopus 로고    scopus 로고
    • Clinical and epidemiological aspects in the antiphospholipid syndrome
    • Cervera R, Asherson RA. Clinical and epidemiological aspects in the antiphospholipid syndrome. Immunobiology 207(1), 5-11 (2003).
    • (2003) Immunobiology , vol.207 , Issue.1 , pp. 5-11
    • Cervera, R.1    Asherson, R.A.2
  • 11
    • 0033007174 scopus 로고    scopus 로고
    • Familial antiphospholipid antibody syndrome: Criteria for disease and evidence for autosomal dominant inheritance
    • Goel N, Ortel TL, Bali D et al. Familial antiphospholipid antibody syndrome: criteria for disease and evidence for autosomal dominant inheritance. Arthritis Rheum. 42(2), 318-327 (1999).
    • (1999) Arthritis Rheum. , vol.42 , Issue.2 , pp. 318-327
    • Goel, N.1    Ortel, T.L.2    Bali, D.3
  • 12
    • 0020035790 scopus 로고
    • Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant
    • De Wolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am. J. Obstet. Gynecol. 142(7), 829-834 (1982).
    • (1982) Am. J. Obstet. Gynecol. , vol.142 , Issue.7 , pp. 829-834
    • De Wolf, F.1    Carreras, L.O.2    Moerman, P.3    Vermylen, J.4    Van Assche, A.5    Renaer, M.6
  • 13
    • 44849103395 scopus 로고    scopus 로고
    • Pathogenic role of antiphospholipid antibodies
    • •• Excellent summary of how antiphospholipid antibodies aPLs mediate tissue injury, particularly that leading to fetal loss
    • Salmon JE, de Groot PG. Pathogenic role of antiphospholipid antibodies. Lupus 17(5), 405-411 (2008). •• Excellent summary of how antiphospholipid antibodies (aPLs) mediate tissue injury, particularly that leading to fetal loss.
    • (2008) Lupus , vol.17 , Issue.5 , pp. 405-411
    • Salmon, J.E.1    De Groot, P.G.2
  • 14
    • 50249174457 scopus 로고    scopus 로고
    • Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: Clinical characteristics, diagnosis, pathogenesis, and treatment
    • • Covers the clinical overlap between systemic lupus erythematosus SLE and APS in pregnancy well
    • Tincani A, Bazzani C, Zingarelli S, Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. Semin. Thromb. Hemost. 34(3), 267-273 (2008). • Covers the clinical overlap between systemic lupus erythematosus (SLE) and APS in pregnancy well.
    • (2008) Semin. Thromb. Hemost. , vol.34 , Issue.3 , pp. 267-273
    • Tincani, A.1    Bazzani, C.2    Zingarelli, S.3    Lojacono, A.4
  • 15
    • 0033826136 scopus 로고    scopus 로고
    • Antiphospholipid antibodymediated disruption of the annexin-V antithrombotic shield: A thrombogenic mechanism for the antiphospholipid syndrome
    • Rand JH. Antiphospholipid antibodymediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome. J. Autoimmun. 15(2), 107-111 (2000).
    • (2000) J. Autoimmun , vol.15 , Issue.2 , pp. 107-111
    • Rand, J.H.1
  • 16
    • 77951217438 scopus 로고    scopus 로고
    • The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: Role in pregnancy losses and thrombosis
    • Rand JH, Wu XX, Quinn AS, Taatjes DJ. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Lupus 19(4), 460-469 (2010).
    • (2010) Lupus , vol.19 , Issue.4 , pp. 460-469
    • Rand, J.H.1    Wu, X.X.2    Quinn, A.S.3    Taatjes, D.J.4
  • 17
    • 67049143455 scopus 로고    scopus 로고
    • Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?
    • Pericleous C, Giles I, Rahman A. Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome? Lupus 18(8), 671-675 (2009).
    • (2009) Lupus , vol.18 , Issue.8 , pp. 671-675
    • Pericleous, C.1    Giles, I.2    Rahman, A.3
  • 18
    • 0034121236 scopus 로고    scopus 로고
    • Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2-glycoprotein I
    • Di Simone N, Meroni PL, de Papa N et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2-glycoprotein I. Arthritis Rheum. 43(1), 140-150 (2000).
    • (2000) Arthritis Rheum. , vol.43 , Issue.1 , pp. 140-150
    • Di Simone, N.1    Meroni, P.L.2    De Papa, N.3
  • 19
    • 0031975690 scopus 로고    scopus 로고
    • The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome
    • Rote NS, Vogt E, DeVere G, Obringer AR, Ng AK. The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am. J. Reprod. Immunol. 39(2), 125-136 (1998).
    • (1998) Am. J. Reprod. Immunol. , vol.39 , Issue.2 , pp. 125-136
    • Rote, N.S.1    Vogt, E.2    DeVere, G.3    Obringer, A.R.4    Ng, A.K.5
  • 20
    • 9144243607 scopus 로고    scopus 로고
    • Heparin prevents antiphospholipid antibodyinduced fetal loss by inhibiting complement activation
    • Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibodyinduced fetal loss by inhibiting complement activation. Nat. Med. 10(11), 1222-1226 (2004).
    • (2004) Nat. Med. , vol.10 , Issue.11 , pp. 1222-1226
    • Girardi, G.1    Redecha, P.2    Salmon, J.E.3
  • 21
    • 34648827566 scopus 로고    scopus 로고
    • Antiphospholipid antibiodies: A critical review of the literature
    • Lim W, Crowther MA. Antiphospholipid antibiodies: a critical review of the literature. Curr. Opin. Hematol. 14(5), 494-499 (2007).
    • (2007) Curr. Opin. Hematol. , vol.14 , Issue.5 , pp. 494-499
    • Lim, W.1    Crowther, M.A.2
  • 22
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    • • Updated Sapporo criteria for the diagnosis of APS
    • Miyakis S, Lockshin MD, Atsumi T et al International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4(2), 295-306 (2006). • Updated Sapporo criteria for the diagnosis of APS.
    • (2006) J. Thromb. Haemost. , vol.4 , Issue.2 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.D.2    Atsumi, T.3
  • 23
    • 60849112831 scopus 로고    scopus 로고
    • How we diagnose the antiphospholipid syndrome
    • Giannakopoulos B, Passam F, Ioannou Y, Krilis SA. How we diagnose the antiphospholipid syndrome. Blood 113(5), 985-994 (2009).
    • (2009) Blood , vol.113 , Issue.5 , pp. 985-994
    • Giannakopoulos, B.1    Passam, F.2    Ioannou, Y.3    Krilis, S.A.4
  • 25
    • 0037370733 scopus 로고    scopus 로고
    • Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature
    • •• Systematic review of literature between 1988 and 2000 involving 25 studies and 4184 patients with 3151 controls that has demonstrated that lupus anticoagulant LA positivity and medium-to-high titres of anticardiolipin antibodies aCLs were useful in picking out patients who were at greatest risk of thrombosis
    • Galli M, Luciani D, Bertolini G, Barbui T Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101(5), 1827-1832 (2003). •• Systematic review of literature between 1988 and 2000 involving 25 studies and 4184 patients with 3151 controls that has demonstrated that lupus anticoagulant (LA) positivity and medium-to-high titres of anticardiolipin antibodies (aCLs) were useful in picking out patients who were at greatest risk of thrombosis.
    • (2003) Blood , vol.101 , Issue.5 , pp. 1827-1832
    • Galli, M.1    Luciani, D.2    Bertolini, G.3    Barbui, T.4
  • 26
    • 33750993762 scopus 로고    scopus 로고
    • Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: A metaanalysis
    • •• Meta-analysis of 25 studies between 1975 and 2003 of recurrent fetal loss RFL in women without autoimmune disease. Authors divided RFL into early <13 weeks and late <24 weeks. They found that there was a strong, consistent and significant association between RFL and LA. aCL was significantly associated with both early and late RFL
    • Opatrny L, David M, Kahn SR, Shrier I, Rey E. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J. Rheumatol. 33(11), 2214-2221 (2006). •• Meta-analysis of 25 studies between 1975 and 2003 of recurrent fetal loss (RFL) in women without autoimmune disease. Authors divided RFL into early (<13 weeks) and late (<24 weeks). They found that there was a strong, consistent and significant association between RFL and LA. aCL was significantly associated with both early and late RFL.
    • (2006) J. Rheumatol. , vol.33 , Issue.11 , pp. 2214-2221
    • Opatrny, L.1    David, M.2    Kahn, S.R.3    Shrier, I.4    Rey, E.5
  • 27
    • 13844312379 scopus 로고    scopus 로고
    • A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and β2-glycoprotein I antibody testing
    • • This quality assurance program run by the Royal Australasian College of Pathologists in 2002 demonstrated a high laboratory variation of numerical results, notable method-based variation and a general lack of consensus in semiquantitative reporting of aCL and β2-glycoprotein-I β2GP-I
    • Favaloro EJ, Wong RC, Silvestrini R, McEvoy R, Jovanovich S, Roberts-Thomson P. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and β2-glycoprotein I antibody testing. Semin. Thromb. Hemost. 31(1), 73-84 (2005). • This quality assurance program run by the Royal Australasian College of Pathologists in 2002 demonstrated a high laboratory variation of numerical results, notable method-based variation and a general lack of consensus in semiquantitative reporting of aCL and β2-glycoprotein-I (β2GP-I).
    • (2005) Semin. Thromb. Hemost. , vol.31 , Issue.1 , pp. 73-84
    • Favaloro, E.J.1    Wong, R.C.2    Silvestrini, R.3    McEvoy, R.4    Jovanovich, S.5    Roberts-Thomson, P.6
  • 28
    • 33748550680 scopus 로고    scopus 로고
    • Anti-β2-glycoprotein I: Prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus
    • • Study to determine the prevalence of anti-β2GP-I in a cohort of patients n = 418 with APS and SLE. The authors found that anti-β2GP-I was present in 44.5% of the cohort, especially the Caucasians. Persistent positivity of IgG anti-β2GP-I was associated with venous thrombosis and IgM anti-β2GP-I with arterial thrombosis
    • Danowski A, Kickler TS, Petri M. Anti-β2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J. Rheumatol. 33(9), 1775-1779 (2006). • Study to determine the prevalence of anti-β2GP-I in a cohort of patients (n = 418) with APS and SLE. The authors found that anti-β2GP-I was present in 44.5% of the cohort, especially the Caucasians. Persistent positivity of IgG anti-β2GP-I was associated with venous thrombosis and IgM anti-β2GP-I with arterial thrombosis.
    • (2006) J. Rheumatol. , vol.33 , Issue.9 , pp. 1775-1779
    • Danowski, A.1    Kickler, T.S.2    Petri, M.3
  • 29
    • 0025997368 scopus 로고
    • Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study
    • Infante-Rivard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N. Engl. J. Med. 325(15), 1063-1066 (1991).
    • (1991) N. Engl. J. Med. , vol.325 , Issue.15 , pp. 1063-1066
    • Infante-Rivard, C.1    David, M.2    Gauthier, R.3    Rivard, G.E.4
  • 30
    • 0026585838 scopus 로고
    • Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
    • Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am. J. Obstet. Gynecol 166(5), 1318-1323 (1992).
    • (1992) Am. J. Obstet. Gynecol. , vol.166 , Issue.5 , pp. 1318-1323
    • Cowchock, F.S.1    Reece, E.A.2    Balaban, D.3    Branch, D.W.4    Plouffe, L.5
  • 31
    • 0031022366 scopus 로고    scopus 로고
    • Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
    • • Seminal paper n = 90 that concluded that treatment with aspirin and heparin leads to a significantly higher rate of live births in women with a history of recurrent miscarriage associated with PLs than that achieved with aspirin alone. There was no difference in outcome between the two treatments in pregnancies that advanced beyond 13 weeks' gestation
    • Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br. Med. J. 314(7076), 253-257 (1997). • Seminal paper (n = 90) that concluded that treatment with aspirin and heparin leads to a significantly higher rate of live births in women with a history of recurrent miscarriage associated with PLs than that achieved with aspirin alone. There was no difference in outcome between the two treatments in pregnancies that advanced beyond 13 weeks' gestation.
    • (1997) Br. Med. J. , vol.314 , Issue.7076 , pp. 253-257
    • Rai, R.1    Cohen, H.2    Dave, M.3    Regan, L.4
  • 32
    • 0033784643 scopus 로고    scopus 로고
    • Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial
    • • Double-blind randomized controlled trial n = 50 carried out in a tertiary obstetric hospital and recurrent miscarriage clinic on women with aPLs but no SLE or thrombotic APS concluded that 85% of the placebo group 17 out of 20 and 80% of the aspirin-treated group 16 out of 20 were delivered of live infants. This suggests that low-dose aspirin has no additional benefit when added to supportive care for women for whom recurrent early fetal loss is the only sequela of the APS
    • Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, Liddell HS, McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am. J. Obstet. Gynecol 183(4), 1008-1012 (2000). • Double-blind randomized controlled trial (n = 50) carried out in a tertiary obstetric hospital and recurrent miscarriage clinic on women with aPLs (but no SLE or thrombotic APS) concluded that 85% of the placebo group (17 out of 20) and 80% of the aspirin-treated group (16 out of 20) were delivered of live infants. This suggests that low-dose aspirin has no additional benefit when added to supportive care for women for whom recurrent early fetal loss is the only sequela of the APS.
    • (2000) Am. J. Obstet. Gynecol. , vol.183 , Issue.4 , pp. 1008-1012
    • Pattison, N.S.1    Chamley, L.W.2    Birdsall, M.3    Zanderigo, A.M.4    Liddell, H.S.5    McDougall, J.6
  • 33
    • 0036711316 scopus 로고    scopus 로고
    • Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment
    • •• Randomized controlled trial involving women n = 119 with RFL and aPLs demonstrated that the addition of low-molecular-weight heparin LMWH did not significantly improve pregnancy outcome
    • Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet. Gynecol. 100(3), 408-413 (2002). •• Randomized controlled trial involving women (n = 119) with RFL and aPLs demonstrated that the addition of low-molecular-weight heparin (LMWH) did not significantly improve pregnancy outcome.
    • (2002) Obstet. Gynecol. , vol.100 , Issue.3 , pp. 408-413
    • Farquharson, R.G.1    Quenby, S.2    Greaves, M.3
  • 34
    • 0029934389 scopus 로고    scopus 로고
    • Antiphospholipid antibodyassociated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
    • • One of the earliest papers demonstrating the benefit of heparin plus aspirin over aspirin alone in improving obstetric outcomes in women with aCLs n = 50; women with LA were excluded
    • Kutteh WH. Antiphospholipid antibodyassociated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am. J. Obstet Gynecol. 174(5), 1584-1589 (1996). • One of the earliest papers demonstrating the benefit of heparin plus aspirin over aspirin alone in improving obstetric outcomes in women with aCLs (n = 50; women with LA were excluded).
    • (1996) Am. J. Obstet. Gynecol. , vol.174 , Issue.5 , pp. 1584-1589
    • Kutteh, W.H.1
  • 35
    • 7944225659 scopus 로고    scopus 로고
    • Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: A randomized pilot trial comparing low molecular weight heparin to unfractionated heparin
    • Stephenson MD, Ballem PJ, Tsang P et al. Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J. Obstet. Gynaecol. Can. 26(8), 729-734 (2004).
    • (2004) J. Obstet. Gynaecol. Can. , vol.26 , Issue.8 , pp. 729-734
    • Stephenson, M.D.1    Ballem, P.J.2    Tsang, P.3
  • 36
    • 14844286167 scopus 로고    scopus 로고
    • Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin
    • Noble LS, Kutteh WH, Lashey N, Franklin RD, Herrada J. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil. Steril 83(3), 684-690 (2005).
    • (2005) Fertil. Steril. , vol.83 , Issue.3 , pp. 684-690
    • Noble, L.S.1    Kutteh, W.H.2    Lashey, N.3    Franklin, R.D.4    Herrada, J.5
  • 37
  • 38
    • 61849105454 scopus 로고    scopus 로고
    • Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes
    • •• Case-control study of 1155 consecutive women vs 105 women with no pregnancy morbidity measuring aPLs in early pregnancy found that aCLs were associated with developing pregnancyinduced hypertension, and aCLs plus LA predicted severe pregnancy-induced hypertension with a 30.8% sensitivity and 99.2% specificity
    • Yamada H, Atsumi T, Kobashi G et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J. Reprod. Immunol. 79(2), 188-195 (2009). •• Case-control study of 1155 consecutive women (vs 105 women with no pregnancy morbidity) measuring aPLs in early pregnancy found that aCLs were associated with developing pregnancyinduced hypertension, and aCLs plus LA predicted severe pregnancy-induced hypertension with a 30.8% sensitivity and 99.2% specificity.
    • (2009) J. Reprod. Immunol. , vol.79 , Issue.2 , pp. 188-195
    • Yamada, H.1    Atsumi, T.2    Kobashi, G.3
  • 39
    • 74949100229 scopus 로고    scopus 로고
    • Thrombotic risk factors: Basic pathophysiology Crit
    • Martinelli I, Bucciarelli P, Mannucci PM. Thrombotic risk factors: basic pathophysiology Crit. Care Med. 38 (Suppl. 2), S3-S9 (2010).
    • (2010) Care Med. , vol.38 , Issue.2 SUPPL.
    • Martinelli, I.1    Bucciarelli, P.2    Mannucci, P.M.3
  • 40
    • 45949094478 scopus 로고    scopus 로고
    • Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
    • DOI 10.1378/chest.08-0761
    • Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (Suppl. 6), 844S-886S (2008). (Pubitemid 351892978)
    • (2008) Chest , vol.133 , Issue.6 SUPPL. 6
    • Bates, S.M.1    Greer, I.A.2    Pabinger, I.3    Sofaer, S.4    Hirsh, J.5
  • 42
    • 0026727718 scopus 로고
    • Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
    • Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet. Gynecol 80(4), 614-620 (1992).
    • (1992) Obstet. Gynecol. , vol.80 , Issue.4 , pp. 614-620
    • Branch, D.W.1    Silver, R.M.2    Blackwell, J.L.3    Reading, J.C.4    Scott, J.R.5
  • 43
  • 44
    • 33947526713 scopus 로고    scopus 로고
    • Venous thromboembolism during pregnancy or postpartum: Findings from the RIETE registry thromb
    • • Large multicenter registry of patients n = 11, 630; however, n = 72 were pregnant and n = 64 postpartum with objectively confirmed venous thromboembolism VTE concluded that risk of deep vein thrombosis begins in the first trimester, and prophylaxis, if indicated, should occur in early gestation
    • Blanco-Molina A, Trujillo-Santos J, Criado J et al. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry Thromb. Haemost. 97(2), 186-190 (2007). • Large multicenter registry of patients (n = 11, 630; however, n = 72 were pregnant and n = 64 postpartum) with objectively confirmed venous thromboembolism (VTE) concluded that risk of deep vein thrombosis begins in the first trimester, and prophylaxis, if indicated, should occur in early gestation.
    • (2007) Haemost. , vol.97 , Issue.2 , pp. 186-190
    • Blanco-Molina, A.1    Trujillo-Santos, J.2    Criado, J.3
  • 45
    • 38949151562 scopus 로고    scopus 로고
    • Antenatal pulmonary embolism: Risk factors, management and outcomes
    • Knight M. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG 115(4), 453-461 (2008).
    • (2008) BJOG , vol.115 , Issue.4 , pp. 453-461
    • Knight, M.1
  • 46
    • 0032908014 scopus 로고    scopus 로고
    • Deep vein thrombosis during pregnancy and the puerperium: A meta-analysis of the period of risk and the leg of presentation
    • • This meta-analysis of 14 studies determined that the period of greatest risk is the postpartum interval, with a relative distribution of 0.23 per day during pregnancy versus 0.82 per day in the postpartum period
    • Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet. Gynecol. Surv. 54(4), 265-271 (1999). • This meta-analysis of 14 studies determined that the period of greatest risk is the postpartum interval, with a relative distribution of 0.23 per day during pregnancy versus 0.82 per day in the postpartum period.
    • (1999) Obstet. Gynecol. Surv. , vol.54 , Issue.4 , pp. 265-271
    • Ray, J.G.1    Chan, W.S.2
  • 47
    • 33749266340 scopus 로고    scopus 로고
    • The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis
    • De Stefano V, Martinelli I, Rossi E et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br. J. Haematol. 135(3), 386-391 (2006).
    • (2006) Br. J. Haematol. , vol.135 , Issue.3 , pp. 386-391
    • De Stefano, V.1    Martinelli, I.2    Rossi, E.3
  • 50
    • 23944452327 scopus 로고    scopus 로고
    • Incidence and risk factors for stroke in pregnancy and the puerperium
    • James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet. Gynecol. 106(3), 509-516 (2005).
    • (2005) Obstet. Gynecol. , vol.106 , Issue.3 , pp. 509-516
    • James, A.H.1    Bushnell, C.D.2    Jamison, M.G.3    Myers, E.R.4
  • 51
    • 0028197405 scopus 로고
    • Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study
    • Lynch A, Marlar R, Murphy J et al Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann. Intern. Med. 120(6), 470-475 (1994).
    • (1994) Ann. Intern. Med. , vol.120 , Issue.6 , pp. 470-475
    • Lynch, A.1    Marlar, R.2    Murphy, J.3
  • 52
    • 36849077283 scopus 로고    scopus 로고
    • Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy
    • • Cohort study n = 216 to determine if specific subtypes of hypertensive disorders were associated with different thrombophilic disorders
    • Ganzevoort W, Rep A, De Vries JI, Bonsel GJ, Wolf H; Petra-Investigators FT. Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy. Hypertens. Pregnancy 26(4), 433-445 (2007). • Cohort study (n = 216) to determine if specific subtypes of hypertensive disorders were associated with different thrombophilic disorders.
    • (2007) Hypertens. Pregnancy , vol.26 , Issue.4 , pp. 433-445
    • Ganzevoort, W.1    Rep, A.2    De Vries, J.I.3    Bonsel, G.J.4    Wolf, H.5    Petra-Investigators, F.T.6
  • 53
    • 0038208243 scopus 로고    scopus 로고
    • Antiphospholipid syndrome: Obstetric diagnosis, management, and controversies
    • Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet. Gynecol. 101(6), 1333-1344 (2003).
    • (2003) Obstet. Gynecol. , vol.101 , Issue.6 , pp. 1333-1344
    • Branch, D.W.1    Khamashta, M.A.2
  • 54
    • 32544441595 scopus 로고    scopus 로고
    • Thrombophilia in pregnancy: A systematic review
    • • This meta-analysis of 79 studies to determine the risk of adverse pregnancy outcome associated with thrombophilias showed that there was a lack of controlled trials on anti-thrombotic intervention to prevent pregnancy complications, and the authors felt that universal screening for thrombophilias cannot be justified at this time
    • Robertson L, Wu O, Langhorne P et al. Thrombophilia in pregnancy: a systematic review. Br. J. Haematol. 132(2), 171-196 (2006). • This meta-analysis of 79 studies to determine the risk of adverse pregnancy outcome associated with thrombophilias showed that there was a lack of controlled trials on anti-thrombotic intervention to prevent pregnancy complications, and the authors felt that universal screening for thrombophilias cannot be justified at this time.
    • (2006) Br. J. Haematol. , vol.132 , Issue.2 , pp. 171-196
    • Robertson, L.1    Wu, O.2    Langhorne, P.3
  • 55
    • 0034872052 scopus 로고    scopus 로고
    • Management of pregnancy in antiphospholipid syndrome
    • •• Outlines the therapeutic options for different clinical scenarios in APS in pregnancy
    • Shehata HA, Nelson-Piercy C, Khamashta MA. Management of pregnancy in antiphospholipid syndrome. Rheum. Dis. Clin. North Am. 27(3), 643-659 (2001). •• Outlines the therapeutic options for different clinical scenarios in APS in pregnancy.
    • (2001) Rheum. Dis. Clin. North Am. , vol.27 , Issue.3 , pp. 643-659
    • Shehata, H.A.1    Nelson-Piercy, C.2    Khamashta, M.A.3
  • 57
    • 2142646370 scopus 로고    scopus 로고
    • Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome
    • Pauzner R, Dulitzky M, Carp H et al Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome. J. Thromb. Haemost. 1(8), 1758-1763 (2003).
    • (2003) J. Thromb. Haemost. , vol.1 , Issue.8 , pp. 1758-1763
    • Pauzner, R.1    Dulitzky, M.2    Carp, H.3
  • 58
    • 13244298591 scopus 로고    scopus 로고
    • The HELLP syndrome in the antiphospholipid syndrome: Retrospective study of 16 cases in 15 women
    • Le Thi Thuong D, Tieulie N, Costedoat N et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann. Rheum. Dis. 64(2), 273-278 (2005).
    • (2005) Ann. Rheum. Dis. , vol.64 , Issue.2 , pp. 273-278
    • Le Thi Thuong, D.1    Tieulie, N.2    Costedoat, N.3
  • 59
    • 0029619074 scopus 로고
    • High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies
    • • Prospective study of pregnancy outcomes in 20 women with APS compared with a healthy cohort of 100 women. Reported a 90% rate of miscarriage in the APS cohort, with 94% occurring in the first trimester and fetal cardiac activity seen in 86% of women before miscarriage. This study, showing unusually high rates of fetal loss, preceded Rai's subsequent study on the use of aspirin and heparin in preventing RFL
    • Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum. Reprod. 10(12), 3301-3304 (1995). • Prospective study of pregnancy outcomes in 20 women with APS compared with a healthy cohort of 100 women. Reported a 90% rate of miscarriage in the APS cohort, with 94% occurring in the first trimester and fetal cardiac activity seen in 86% of women before miscarriage. This study, showing unusually high rates of fetal loss, preceded Rai's subsequent study on the use of aspirin and heparin in preventing RFL.
    • (1995) Hum. Reprod. , vol.10 , Issue.12 , pp. 3301-3304
    • Rai, R.S.1    Clifford, K.2    Cohen, H.3    Regan, L.4
  • 60
    • 0025789676 scopus 로고
    • The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction
    • Polzin WJ, Kopelman JN, Robinson RD, Read JA, Brady K. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstet. Gynecol. 78(6), 1108-1111 (1991).
    • (1991) Obstet. Gynecol. , vol.78 , Issue.6 , pp. 1108-1111
    • Polzin, W.J.1    Kopelman, J.N.2    Robinson, R.D.3    Read, J.A.4    Brady, K.5
  • 61
    • 33645077875 scopus 로고    scopus 로고
    • The placental bed in pregnancies complicated by primary antiphospholipid syndrome
    • •• A small study of women with complicated APS n = 33 demonstrated that the use of a standardized protocol provides a framework for the management of the diverse clinical phenotypes in APS and results in excellent outcomes 91% live birth rates
    • Stone S, Pijnenborg R, Vercruysse L et al The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 27 (4-5), 457-467 (2006). •• A small study of women with complicated APS (n = 33) demonstrated that the use of a standardized protocol provides a framework for the management of the diverse clinical phenotypes in APS and results in excellent outcomes (91% live birth rates).
    • (2006) Placenta , vol.27 , Issue.4-5 , pp. 457-467
    • Stone, S.1    Pijnenborg, R.2    Vercruysse, L.3
  • 62
    • 21344457628 scopus 로고    scopus 로고
    • Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome
    • Cervera R, Font J, Gomez-Puerta JA et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann. Rheum. Dis. 64(8), 1205-1209 (2005).
    • (2005) Ann. Rheum. Dis. , vol.64 , Issue.8 , pp. 1205-1209
    • Cervera, R.1    Font, J.2    Gomez-Puerta, J.A.3
  • 63
    • 0038376616 scopus 로고    scopus 로고
    • Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines
    • Asherson RA, Cervera R, de Groot PG et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12(7), 530-534 (2003).
    • (2003) Lupus , vol.12 , Issue.7 , pp. 530-534
    • Asherson, R.A.1    Cervera, R.2    De Groot, P.G.3
  • 64
    • 68949181872 scopus 로고    scopus 로고
    • The CAPS Registry: Morbidity and mortality of the catastrophic antiphospholipid syndrome
    • Bucciarelli S, Espinosa G, Cervera R. The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome. Lupus 18(10), 905-912 (2009).
    • (2009) Lupus , vol.18 , Issue.10 , pp. 905-912
    • Bucciarelli, S.1    Espinosa, G.2    Cervera, R.3
  • 65
    • 34249806311 scopus 로고    scopus 로고
    • Catastrophic antiphospholipid syndrome during pregnancy and puerperium: Maternal and fetal characteristics of 15 cases
    • • Highlights the need for clinicians to be aware of catastrophic APS
    • Gomez-Puerta JA, Cervera R, Espinosa G et al. Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases. Ann. Rheum. Dis. 66(6), 740-746 (2007). • Highlights the need for clinicians to be aware of catastrophic APS.
    • (2007) Ann. Rheum. Dis. , vol.66 , Issue.6 , pp. 740-746
    • Gomez-Puerta, J.A.1    Cervera, R.2    Espinosa, G.3
  • 66
    • 74849134126 scopus 로고    scopus 로고
    • Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome
    • •• A study n = 83 pregnancies that attempts to tailor the management of APS according to clinical phenotype concluded that women with thrombotic APS have more pregnancy-related complications than those with obstetric APS, and that treatment with aspirin and LMWH is associated with improved outcomes for women with previous late fetal loss or early delivery due to placental dysfunction
    • Bramham K, Hunt BJ, Germain S et al Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 19(1), 58-64 (2009). •• A study (n = 83 pregnancies) that attempts to tailor the management of APS according to clinical phenotype concluded that women with thrombotic APS have more pregnancy-related complications than those with obstetric APS, and that treatment with aspirin and LMWH is associated with improved outcomes for women with previous late fetal loss or early delivery due to placental dysfunction.
    • (2009) Lupus , vol.19 , Issue.1 , pp. 58-64
    • Bramham, K.1    Hunt, B.J.2    Germain, S.3
  • 67
    • 70349312358 scopus 로고    scopus 로고
    • Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome
    • Habli M, Eftekhari N, Wiebracht E et al Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am. J. Obstet. Gynecol. 201(4), 385.e1-5 (2009).
    • (2009) Am. J. Obstet. Gynecol. , vol.201 , Issue.4
    • Habli, M.1    Eftekhari, N.2    Wiebracht, E.3
  • 68
    • 0028908906 scopus 로고
    • Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Subsequent pregnancy outcome and long-term prognosis
    • 1
    • Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am. J. Obstet. Gynecol. 172 (1 Pt 1), 125-129 (1995).
    • (1995) Am. J. Obstet. Gynecol. , vol.172 , Issue.1 PART , pp. 125-129
    • Sibai, B.M.1    Ramadan, M.K.2    Chari, R.S.3    Friedman, S.A.4
  • 69
    • 0027940372 scopus 로고
    • The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations
    • Sullivan CA, Magann EF, Perry KG Jr, Roberts WE, Blake PG, Martin JN Jr. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am. J. Obstet. Gynecol. 171(4), 940-943 (1994).
    • (1994) Am. J. Obstet. Gynecol. , vol.171 , Issue.4 , pp. 940-943
    • Sullivan, C.A.1    Magann, E.F.2    Perry Jr., K.G.3    Roberts, W.E.4    Blake, P.G.5    Martin Jr., J.N.6
  • 70
    • 34248176839 scopus 로고    scopus 로고
    • Lupus activity in pregnancy
    • •• Cohort study n = 267 pregnancies that prospectively followed up women with SLE in the Hopkin's Lupus Center MD, USA between 1987 and 2002 concluded that high-activity lupus during pregnancy leads to increased premature birth and a decrease in live births, with almost one-quarter of these pregnancies resulting in fetal loss. They recommended that pregnancies in lupus patients must be closely watched and treated during all trimesters to improve pregnancy outcomes
    • Clowse ME. Lupus activity in pregnancy. Rheum. Dis. Clin. North Am. 33(2), 237-252 (2007). •• Cohort study (n = 267 pregnancies) that prospectively followed up women with SLE in the Hopkin's Lupus Center (MD, USA) between 1987 and 2002 concluded that high-activity lupus during pregnancy leads to increased premature birth and a decrease in live births, with almost one-quarter of these pregnancies resulting in fetal loss. They recommended that pregnancies in lupus patients must be closely watched and treated during all trimesters to improve pregnancy outcomes.
    • (2007) Rheum. Dis. Clin. North Am. , vol.33 , Issue.2 , pp. 237-252
    • Clowse, M.E.1
  • 71
    • 47949126782 scopus 로고    scopus 로고
    • A national study of the complications of lupus in pregnancy
    • •• A nationwide inpatient sample of all women with SLE and pregnancy complications between 2000 and 2003 found that maternal mortality was 20-fold higher among women with SLE. The risks for thrombosis, infection, thrombocytopenia and transfusion were three to sevenfold higher for women with SLE. These women were also more likely to have other associated medical disorders such as diabetes, hypertension and thrombophilia
    • Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am. J. Obstet. Gynecol. 199(2), 127e1-6 (2008). •• A nationwide inpatient sample of all women with SLE and pregnancy complications between 2000 and 2003 found that maternal mortality was 20-fold higher among women with SLE. The risks for thrombosis, infection, thrombocytopenia and transfusion were three to sevenfold higher for women with SLE. These women were also more likely to have other associated medical disorders such as diabetes, hypertension and thrombophilia.
    • (2008) Am. J. Obstet. Gynecol. , vol.199 , Issue.2
    • Clowse, M.E.1    Jamison, M.2    Myers, E.3    James, A.H.4
  • 72
    • 0141754190 scopus 로고    scopus 로고
    • Preterm deliveries in women with systemic lupus erythematosus
    • Clark CA, Spitzer KA, Nadler JN, Laskin CA. Preterm deliveries in women with systemic lupus erythematosus. J. Rheumatol. 30(10), 2127-2132 (2003).
    • (2003) J. Rheumatol. , vol.30 , Issue.10 , pp. 2127-2132
    • Clark, C.A.1    Spitzer, K.A.2    Nadler, J.N.3    Laskin, C.A.4
  • 73
    • 4644340818 scopus 로고    scopus 로고
    • Prospective study of systemic lupus erythematosus pregnancies
    • DOI 10.1191/0961203303lu2006oa
    • Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus 13(9), 688-689 (2004). (Pubitemid 39279785)
    • (2004) Lupus , vol.13 , Issue.9 , pp. 688-689
    • Petri, M.1
  • 74
    • 34249034723 scopus 로고    scopus 로고
    • Antiplatelet agents for preventing pre-eclampsia and its complications
    • •• Systematic review that shows that low-dose aspirin has a modest beneficial effect in the prevention of preeclampsia in pregnancy
    • Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst. Rev. 2, CD004659 (2007). •• Systematic review that shows that low-dose aspirin has a modest beneficial effect in the prevention of preeclampsia in pregnancy.
    • (2007) Cochrane Database Syst. Rev. , vol.2
    • Duley, L.1    Henderson-Smart, D.J.2    Meher, S.3    King, J.F.4
  • 75
    • 0034810266 scopus 로고    scopus 로고
    • Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis
    • • The study of 77 pregnancies in 56 women with APS concluded that aspirin started preconceptually was an independent and significant prognostic factor associated with favorable fetal outcome
    • Carmona F, Font J, Azulay M et al. Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. Am. J. Reprod. Immunol. 46(4), 274-279 (2001). • The study of 77 pregnancies in 56 women with APS concluded that aspirin started preconceptually was an independent and significant prognostic factor associated with favorable fetal outcome.
    • (2001) Am. J. Reprod. Immunol. , vol.46 , Issue.4 , pp. 274-279
    • Carmona, F.1    Font, J.2    Azulay, M.3
  • 76
    • 0030614449 scopus 로고    scopus 로고
    • Hopkins lupus pregnancy center: 1987 to 1996
    • Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum. Dis. Clin. North Am. 23(1), 1-13 (1997).
    • (1997) Rheum. Dis. Clin. North Am. , vol.23 , Issue.1 , pp. 1-13
    • Petri, M.1
  • 77
    • 34248154135 scopus 로고    scopus 로고
    • The hopkins lupus pregnancy center: Ten key issues in management
    • Petri M. The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum. Dis. Clin. North Am. 33(2), 227-235, v (2007).
    • (2007) Rheum. Dis. Clin. North Am. , vol.33 , Issue.2 , pp. 227-235
    • Petri, M.1
  • 78
    • 0034881072 scopus 로고    scopus 로고
    • Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome
    • Venkat-Raman N, Backos M, Teoh TG, Lo W T, Regan L. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Obstet. Gynecol. 98(2), 235-242 (2001).
    • (2001) Obstet. Gynecol. , vol.98 , Issue.2 , pp. 235-242
    • Venkat-Raman, N.1    Backos, M.2    Teoh, T.G.3    Lo, W.T.4    Regan, L.5
  • 81
    • 77953101173 scopus 로고    scopus 로고
    • The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants
    • Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J. Am. Coll. Cardiol. 55(24), 2778-2784 (2010).
    • (2010) J. Am. Coll. Cardiol. , vol.55 , Issue.24 , pp. 2778-2784
    • Jaeggi, E.1    Laskin, C.2    Hamilton, R.3    Kingdom, J.4    Silverman, E.5
  • 82
    • 0026329304 scopus 로고
    • Frequency of lupus flare in pregnancy. The Hopkins lupus pregnancy center experience
    • Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 34(12), 1538-1545 (1991).
    • (1991) Arthritis Rheum. , vol.34 , Issue.12 , pp. 1538-1545
    • Petri, M.1    Howard, D.2    Repke, J.3
  • 84
    • 77950645926 scopus 로고    scopus 로고
    • The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications
    • Gladman DD, Tandon A, Ibanez D, Urowitz MB. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J. Rheumatol. 37(4), 754-758 (2010).
    • (2010) J. Rheumatol. , vol.37 , Issue.4 , pp. 754-758
    • Gladman, D.D.1    Tandon, A.2    Ibanez, D.3    Urowitz, M.B.4
  • 85
    • 0027263663 scopus 로고
    • Fetal outcome of lupus pregnancy: A retrospective case-control study of the Hopkins lupus cohort
    • Petri M, Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins lupus cohort. J. Rheumatol. 20(4), 650-656 (1993).
    • (1993) J. Rheumatol. , vol.20 , Issue.4 , pp. 650-656
    • Petri, M.1    Allbritton, J.2
  • 89
    • 0027048501 scopus 로고
    • Uterine-umbilical artery Doppler velocimetry in pregnant women with systemic lupus erythematosus
    • Guzman E, Schulman H, Bracero L, Rochelson B, Farmakides G, Coury A. Uterine-umbilical artery Doppler velocimetry in pregnant women with systemic lupus erythematosus. J. Ultrasound Med. 11(6), 275-281 (1992).
    • (1992) J. Ultrasound Med. , vol.11 , Issue.6 , pp. 275-281
    • Guzman, E.1    Schulman, H.2    Bracero, L.3    Rochelson, B.4    Farmakides, G.5    Coury, A.6
  • 90
    • 33644865455 scopus 로고    scopus 로고
    • The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome
    • Le Thi Huong D, Wechsler B, Vauthier-Brouzes D et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 45(3), 332-338 (2006).
    • (2006) Rheumatology (Oxford) , vol.45 , Issue.3 , pp. 332-338
    • Le Thi Huong, D.1    Wechsler, B.2    Vauthier-Brouzes, D.3
  • 91
    • 0028091212 scopus 로고
    • Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation
    • North RA, Ferrier C, Long D, Townend K, Kincaid-Smith P. Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation. Obstet. Gynecol. 83(3), 378-386 (1994).
    • (1994) Obstet. Gynecol. , vol.83 , Issue.3 , pp. 378-386
    • North, R.A.1    Ferrier, C.2    Long, D.3    Townend, K.4    Kincaid-Smith, P.5
  • 92
    • 0036145638 scopus 로고    scopus 로고
    • Recurrent pregnancy loss with antiphospholipid antibody: A systematic review of therapeutic trials
    • DOI 10.1016/S0029-7844(01)01646-5, PII S0029784401016465
    • Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet. Gynecol 99(1), 135-144 (2002). •• Systematic review of all studies and the Cochrane database concluded that heparin combined with aspirin (two trials; 140 patients) significantly reduced pregnancy loss compared with aspirin alone (relative risk [RR]: 0.46; 95% CI: 0.29-0.71). Prednisone and aspirin resulted in a significant increase in prematurity (RR: 4.83; 95% CI: 2.85-8.21) but no significant reduction in pregnancy loss (RR: 0.85; 95% CI: 0.53-1.36). (Pubitemid 34075480)
    • (2002) Obstetrics and Gynecology , vol.99 , Issue.1 , pp. 135-144
    • Empson, M.1    Lassere, M.2    Craig, J.C.3    Scott, J.R.4
  • 93
    • 20844444461 scopus 로고    scopus 로고
    • Primary antiphospholipid syndrome in pregnancy: An analysis of outcome in a cohort of 33 women treated with a rigorous protocol
    • DOI 10.1111/j.1538-7836.2005.01185.x
    • Stone S, Hunt BJ, Khamashta MA, Bewley SJ, Nelson-Piercy C. Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol. J. Thromb. Haemost. 3(2), 243-245 (2005). (Pubitemid 41623610)
    • (2005) Journal of Thrombosis and Haemostasis , vol.3 , Issue.2 , pp. 243-245
    • Stone, S.1    Hunt, B.J.2    Khamashta, M.A.3    Bewley, S.J.4    Nelson-Piercy, C.5
  • 94
    • 0033133401 scopus 로고    scopus 로고
    • Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves
    • Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J. Am. Coll. Cardiol. 33(6), 1637-1641 (1999).
    • (1999) J. Am. Coll. Cardiol. , vol.33 , Issue.6 , pp. 1637-1641
    • Vitale, N.1    De Feo, M.2    De Santo, L.S.3    Pollice, A.4    Tedesco, N.5    Cotrufo, M.6
  • 95
    • 0033968044 scopus 로고    scopus 로고
    • Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves
    • Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG 107(2), 245-253 (2000).
    • (2000) BJOG , vol.107 , Issue.2 , pp. 245-253
    • Sadler, L.1    McCowan, L.2    White, H.3    Stewart, A.4    Bracken, M.5    North, R.6
  • 96
    • 64849104901 scopus 로고    scopus 로고
    • Low molecular weight heparin and aspirin for recurrent pregnancy loss: Results from the randomized, controlled HepASA Trial
    • •• Prospective study of pregnant women n = 88 with recurrent pregnancy loss RPL with either APS, an inherited thrombophilia or antinuclear antibody who were randomized to receive either aspirin or aspirin plus LMWH, which found that regardless of the treatment regimen, the number of prior losses or aPL positivity, almost 80% of women in the RPL cohort had a successful pregnancy outcome. Hence, LMWH did not confer additional benefit over the use of aspirin alone
    • Laskin CA, Spitzer KA, Clark CA et al Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J. Rheumatol. 36(2), 279-287 (2009). •• Prospective study of pregnant women (n = 88) with recurrent pregnancy loss (RPL) with either APS, an inherited thrombophilia or antinuclear antibody who were randomized to receive either aspirin or aspirin plus LMWH, which found that regardless of the treatment regimen, the number of prior losses or aPL positivity, almost 80% of women in the RPL cohort had a successful pregnancy outcome. Hence, LMWH did not confer additional benefit over the use of aspirin alone.
    • (2009) J. Rheumatol. , vol.36 , Issue.2 , pp. 279-287
    • Laskin, C.A.1    Spitzer, K.A.2    Clark, C.A.3
  • 97
    • 0024578482 scopus 로고
    • Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody
    • Lockshin MD, Druzin ML, Qamar T Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am. J. Obstet. Gynecol. 160(2), 439-443 (1989).
    • (1989) Am. J. Obstet. Gynecol. , vol.160 , Issue.2 , pp. 439-443
    • Lockshin, M.D.1    Druzin, M.L.2    Qamar, T.3
  • 98
    • 0027144129 scopus 로고
    • Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients
    • Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am. J. Obstet. Gynecol 169(6), 1411-1417 (1993).
    • (1993) Am. J. Obstet. Gynecol. , vol.169 , Issue.6 , pp. 1411-1417
    • Silver, R.K.1    MacGregor, S.N.2    Sholl, J.S.3    Hobart, J.M.4    Neerhof, M.G.5    Ragin, A.6
  • 99
    • 62849100961 scopus 로고    scopus 로고
    • New approaches for managing antiphospholipid syndrome
    • Erkan D, Lockshin MD. New approaches for managing antiphospholipid syndrome. Nat. Clin. Pract. Rheumatol. 5(3), 160-170 (2009).
    • (2009) Nat. Clin. Pract. Rheumatol. , vol.5 , Issue.3 , pp. 160-170
    • Erkan, D.1    Lockshin, M.D.2
  • 100
    • 0036123462 scopus 로고    scopus 로고
    • Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies
    • Espinola RG, Pierangeli SS, Gharavi AE, Harris EN. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost. 87(3), 518-522 (2002).
    • (2002) Thromb. Haemost. , vol.87 , Issue.3 , pp. 518-522
    • Espinola, R.G.1    Pierangeli, S.S.2    Gharavi, A.E.3    Harris, E.N.4
  • 101
    • 33750955870 scopus 로고    scopus 로고
    • Hydroxychloroquine in lupus pregnancy
    • •• Prospective follow-up of women from the Hopkins Lupus Center between 1987 and 2002 n = 163 concluded with the recommendation that hydroxychloroquine be continued during pregnancy, as it was associated with a lower rate of lupus flares and the women could be maintained on a lower average dose of prednisone during pregnancy
    • Clowse ME, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 54(11), 3640-3647 (2006). •• Prospective follow-up of women from the Hopkins Lupus Center between 1987 and 2002 (n = 163) concluded with the recommendation that hydroxychloroquine be continued during pregnancy, as it was associated with a lower rate of lupus flares and the women could be maintained on a lower average dose of prednisone during pregnancy.
    • (2006) Arthritis Rheum. , vol.54 , Issue.11 , pp. 3640-3647
    • Clowse, M.E.1    Magder, L.2    Witter, F.3    Petri, M.4
  • 102
    • 13444268965 scopus 로고    scopus 로고
    • The impact of increased lupus activity on obstetric outcomes
    • Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 52(2), 514-521 (2005).
    • (2005) Arthritis Rheum. , vol.52 , Issue.2 , pp. 514-521
    • Clowse, M.E.1    Magder, L.S.2    Witter, F.3    Petri, M.4
  • 103
    • 48749104624 scopus 로고    scopus 로고
    • Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-β2-glycoprotein I complexes to phospholipid bilayers
    • Rand JH, Wu XX, Quinn AS, Chen PP, Hathcock JJ, Taatjes DJ. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-β2-glycoprotein I complexes to phospholipid bilayers. Blood 112(5), 1687-1695 (2008).
    • (2008) Blood , vol.112 , Issue.5 , pp. 1687-1695
    • Rand, J.H.1    Wu, X.X.2    Quinn, A.S.3    Chen, P.P.4    Hathcock, J.J.5    Taatjes, D.J.6
  • 104
    • 77950435764 scopus 로고    scopus 로고
    • Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: Evidence for a novel effect for an old antimalarial drug
    • Rand JH, Wu XX, Quinn AS et al. Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug. Blood 115(11), 2292-2299 (2010).
    • (2010) Blood , vol.115 , Issue.11 , pp. 2292-2299
    • Rand, J.H.1    Wu, X.X.2    Quinn, A.S.3
  • 105
    • 0037270081 scopus 로고    scopus 로고
    • Quinacrine added to ongoing therapeutic regimens attenuates anticardiolipin antibody production in SLE
    • Toubi E, Kessel A, Rosner I et al. Quinacrine added to ongoing therapeutic regimens attenuates anticardiolipin antibody production in SLE. Lupus 12(4), 297-301 (2003).
    • (2003) Lupus , vol.12 , Issue.4 , pp. 297-301
    • Toubi, E.1    Kessel, A.2    Rosner, I.3
  • 106
    • 77957278745 scopus 로고    scopus 로고
    • Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine
    • Izmirly PM, Kim MY, Llanos C et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann. Rheum. Dis. 69(10), 1827-1830 (2010).
    • (2010) Ann. Rheum. Dis. , vol.69 , Issue.10 , pp. 1827-1830
    • Izmirly, P.M.1    Kim, M.Y.2    Llanos, C.3
  • 107
    • 67449135232 scopus 로고    scopus 로고
    • Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases
    • Sperber K, Hom C, Chao CP, Shapiro D, Ash J. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr. Rheumatol. Online J. 7, 9(2009).
    • (2009) Pediatr. Rheumatol. Online J. , vol.7 , pp. 9
    • Sperber, K.1    Hom, C.2    Chao, C.P.3    Shapiro, D.4    Ash, J.5
  • 108
    • 20944448673 scopus 로고    scopus 로고
    • Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation
    • Motta M, Tincani A, Faden D et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J. Perinatol. 25(2), 86-89 (2005).
    • (2005) J. Perinatol. , vol.25 , Issue.2 , pp. 86-89
    • Motta, M.1    Tincani, A.2    Faden, D.3
  • 109
    • 0037334440 scopus 로고    scopus 로고
    • Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies
    • Triolo G, Ferrante A, Ciccia F et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum. 48(3), 728-731 (2003).
    • (2003) Arthritis Rheum. , vol.48 , Issue.3 , pp. 728-731
    • Triolo, G.1    Ferrante, A.2    Ciccia, F.3
  • 110
    • 0033979270 scopus 로고    scopus 로고
    • A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The pregnancy loss study group
    • 1
    • Branch DW, Peaceman AM, Druzin M et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am. J. Obstet. Gynecol. 182 (1 Pt 1), 122-127 (2000).
    • (2000) Am. J. Obstet. Gynecol. , vol.182 , Issue.1 PART , pp. 122-127
    • Branch, D.W.1    Peaceman, A.M.2    Druzin, M.3
  • 111
    • 0032144490 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus
    • DOI 10.1016/S0301-2115(98)00070-0, PII S0301211598000700
    • Somerset DA, Raine-Fenning N, Gordon C, Weaver JB, Kilby MD. Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus. Eur. J. Obstet. Gynecol. Reprod. Biol. 79(2), 227-229 (1998). (Pubitemid 28294921)
    • (1998) European Journal of Obstetrics Gynecology and Reproductive Biology , vol.79 , Issue.2 , pp. 227-229
    • Somerset, D.A.1    Raine-Fenning, N.2    Gordon, C.3    Weaver, J.B.4    Kilby, M.D.5
  • 112
    • 61349196388 scopus 로고    scopus 로고
    • Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: Report of four cases and review of the literature
    • Bortolati M, Marson P, Fabris F et al. Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature. Autoimmun. Rev. 8(4), 297-301 (2009).
    • (2009) Autoimmun. Rev. , vol.8 , Issue.4 , pp. 297-301
    • Bortolati, M.1    Marson, P.2    Fabris, F.3
  • 113
    • 0024372164 scopus 로고
    • Plasma exchange and the anticardiolipin syndrome in pregnancy
    • Fulcher D, Stewart G, Exner T, Trudinger B, Jeremy R. Plasma exchange and the anticardiolipin syndrome in pregnancy. Lancet 2(8655), 171(1989).
    • (1989) Lancet , vol.2 , Issue.8655 , pp. 171
    • Fulcher, D.1    Stewart, G.2    Exner, T.3    Trudinger, B.4    Jeremy, R.5
  • 114
    • 0028226537 scopus 로고
    • Epoprostenol and plasmapheresis in complicated HELLP syndrome with pancreatitis
    • Huber W, Schweigart U, Classen M. Epoprostenol and plasmapheresis in complicated HELLP syndrome with pancreatitis. Lancet 343(8901), 848(1994).
    • (1994) Lancet , vol.343 , Issue.8901 , pp. 848
    • Huber, W.1    Schweigart, U.2    Classen, M.3
  • 116
    • 34548321503 scopus 로고    scopus 로고
    • Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjogren's syndrome
    • Makino S, Yonemoto H, Itoh S, Takeda S. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjogren's syndrome. Acta Obstet. Gynecol. Scand. 86(9), 1145-1146 (2007).
    • (2007) Acta Obstet. Gynecol. Scand. , vol.86 , Issue.9 , pp. 1145-1146
    • Makino, S.1    Yonemoto, H.2    Itoh, S.3    Takeda, S.4
  • 117
    • 46749083834 scopus 로고    scopus 로고
    • Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: Case reports
    • Alallam A, Barth D, Heathcote EJ. Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports. Can. J. Gastroenterol. 22(5), 505-507 (2008).
    • (2008) Can. J. Gastroenterol. , vol.22 , Issue.5 , pp. 505-507
    • Alallam, A.1    Barth, D.2    Heathcote, E.J.3
  • 118
  • 119
    • 0035691599 scopus 로고    scopus 로고
    • Hematological malignancies and pregnancy: A final report of 84 children who received chemotherapy in utero
    • Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin. Lymphoma 2(3), 173-177 (2001).
    • (2001) Clin. Lymphoma , vol.2 , Issue.3 , pp. 173-177
    • Aviles, A.1    Neri, N.2
  • 120
    • 47349116535 scopus 로고    scopus 로고
    • Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development
    • Klink DT, van Elburg RM, Schreurs MW, van Well GT. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin. Dev. Immunol. 2008, 271363(2008).
    • (2008) Clin. Dev. Immunol. , vol.2008 , pp. 271363
    • Klink, D.T.1    Van Elburg, R.M.2    Schreurs, M.W.3    Van Well, G.T.4
  • 121
    • 66349089572 scopus 로고    scopus 로고
    • Reviewing the evidence for mycophenolate mofetil as a new teratogen: Case report and review of the literature
    • Anderka MT, Lin AE, Abuelo DN, Mitchell AA, Rasmussen SA. Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am. J. Med. Genet. A 149 A (6), 1241-1248 (2009).
    • (2009) Am. J. Med. Genet. A , vol.149 A , Issue.6 , pp. 1241-1248
    • Anderka, M.T.1    Lin, A.E.2    Abuelo, D.N.3    Mitchell, A.A.4    Rasmussen, S.A.5
  • 122
    • 77951724860 scopus 로고    scopus 로고
    • Aspirin plus heparin or aspirin alone in women with recurrent miscarriage
    • • Randomized controlled trial of aspirin with or without LMWH nadroparin or placebo in women n = 364 with unexplained recurrent miscarriages showed that this intervention was of little therapeutic benefit in improving the rate of live births
    • Kaandorp SP, Goddijn M, van der Post JA et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N. Engl. J. Med. 362(17), 1586-1596 (2010). • Randomized controlled trial of aspirin with or without LMWH (nadroparin) or placebo in women (n = 364) with unexplained recurrent miscarriages showed that this intervention was of little therapeutic benefit in improving the rate of live births.
    • (2010) N. Engl. J. Med. , vol.362 , Issue.17 , pp. 1586-1596
    • Kaandorp, S.P.1    Goddijn, M.2    Van Der Post, J.A.3
  • 123
    • 77951714717 scopus 로고    scopus 로고
    • SPIN (Scottish pregnancy intervention) study: A multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage
    • • This study of women n = 294 with more than two unexplained miscarriages at 24 weeks or less women with APS were excluded who were randomized to receive either aspirin 75 mg plus LMWH enoxaparin 40 mg plus intense pregnancy surveillance or intense pregnancy surveillance alone, found that there was no difference in the rates of pregnancy losses between the two groups
    • Clark P, Walker ID, Langhorne P et al SPIN (Scottish Pregnancy
    • (2010) Blood , vol.115 , Issue.21 , pp. 4162-4167
    • Clark, P.1    Walker, I.D.2    Langhorne, P.3
  • 124
    • 4644254522 scopus 로고    scopus 로고
    • The management of pregnant patients with antiphospholipid syndrome
    • Cervera R, Balasch J. The management of pregnant patients with antiphospholipid syndrome. Lupus 13(9), 683-687 (2004).
    • (2004) Lupus , vol.13 , Issue.9 , pp. 683-687
    • Cervera, R.1    Balasch, J.2
  • 126
    • 34248649846 scopus 로고    scopus 로고
    • Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss
    • Clark CA, Spitzer KA, Crowther MA et al Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss. J. Rheumatol. 34(5), 992-996 (2007).
    • (2007) J. Rheumatol. , vol.34 , Issue.5 , pp. 992-996
    • Clark, C.A.1    Spitzer, K.A.2    Crowther, M.A.3
  • 127
    • 0030988825 scopus 로고    scopus 로고
    • Effect of antiphospholipid antibodies in women undergoing in vitro fertilization: Role of heparin and aspirin
    • Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in vitro fertilization: role of heparin and aspirin. Hum. Reprod. 12(6), 1171-1175 (1997).
    • (1997) Hum. Reprod. , vol.12 , Issue.6 , pp. 1171-1175
    • Kutteh, W.H.1    Yetman, D.L.2    Chantilis, S.J.3    Crain, J.4
  • 128
    • 33644695013 scopus 로고    scopus 로고
    • The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies
    • Goel N, Tuli A, Choudhry R. The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies. Med. Sci. Monit. 12(3), CR132-CR136 (2006).
    • (2006) Med. Sci. Monit. , vol.12 , Issue.3
    • Goel, N.1    Tuli, A.2    Choudhry, R.3
  • 129
    • 0036851150 scopus 로고    scopus 로고
    • Antiphospholipid antibodies (APA) and recurrent pregnancy loss: Treating a unique APA positive population
    • Franklin RD, Kutteh WH. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum. Reprod. 17(11), 2981-2985 (2002).
    • (2002) Hum. Reprod. , vol.17 , Issue.11 , pp. 2981-2985
    • Franklin, R.D.1    Kutteh, W.H.2
  • 130
    • 57749201156 scopus 로고    scopus 로고
    • Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: A pilot randomized controlled trial
    • Rey E, Garneau P, David M et al Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J. Thromb. Haemost. 7(1), 58-64 (2009).
    • (2009) J. Thromb. Haemost. , vol.7 , Issue.1 , pp. 58-64
    • Rey, E.1    Garneau, P.2    David, M.3
  • 131
    • 1842632417 scopus 로고    scopus 로고
    • Management of the obstetric antiphospholipid syndrome
    • Derksen RH, Khamashta MA, Branch DW Management of the obstetric antiphospholipid syndrome. Arthritis Rheum. 50(4), 1028-1039 (2004).
    • (2004) Arthritis Rheum. , vol.50 , Issue.4 , pp. 1028-1039
    • Derksen, R.H.1    Khamashta, M.A.2    Branch, D.W.3
  • 132
    • 66849101980 scopus 로고    scopus 로고
    • A risk score for the management of pregnant women with increased risk of venous thromboembolism: A multicentre prospective study
    • Dargaud Y, Rugeri L, Vergnes MC et al. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study. Br. J. Haematol. 145(6), 825-835 (2009).
    • (2009) Br. J. Haematol. , vol.145 , Issue.6 , pp. 825-835
    • Dargaud, Y.1    Rugeri, L.2    Vergnes, M.C.3
  • 133
    • 36949015392 scopus 로고    scopus 로고
    • Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women
    • •• A study of 810 women at increased risk of VTE inclusive of women with APS and other thrombophilias during pregnancy who underwent a strategy of risk-stratified heparin prophylaxis showed that this resulted in a very low rate of symptomatic VTE 0.6% and serious bleeds 3%
    • Bauersachs RM, Dudenhausen J et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb. Haemost. 98(6), 1237-1245 (2007). •• A study of 810 women at increased risk of VTE (inclusive of women with APS and other thrombophilias) during pregnancy who underwent a strategy of risk-stratified heparin prophylaxis showed that this resulted in a very low rate of symptomatic VTE (0.6%) and serious bleeds (3%).
    • (2007) Thromb. Haemost. , vol.98 , Issue.6 , pp. 1237-1245
    • Bauersachs, R.M.1    Dudenhausen, J.2
  • 134
    • 0035652633 scopus 로고    scopus 로고
    • Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy
    • Pauzner R, Dulitzki M, Langevitz P, Livneh A, Kenett R, Many A. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb. Haemost. 86(6), 1379-1384 (2001).
    • (2001) Thromb. Haemost. , vol.86 , Issue.6 , pp. 1379-1384
    • Pauzner, R.1    Dulitzki, M.2    Langevitz, P.3    Livneh, A.4    Kenett, R.5    Many, A.6
  • 135
    • 0036926703 scopus 로고    scopus 로고
    • Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: A single center retrospective study of 21 cases and 114 cycles
    • Huong DL, Wechsler B, Vauthier-Brouzes D et al. Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles. Semin. Arthritis Rheum. 32(3), 174-188 (2002).
    • (2002) Semin. Arthritis Rheum. , vol.32 , Issue.3 , pp. 174-188
    • Huong, D.L.1    Wechsler, B.2    Vauthier-Brouzes, D.3
  • 136
    • 54549099356 scopus 로고    scopus 로고
    • Management of the controversial aspects of antiphospholipid syndrome pregnancies: A guide for clinicians and researchers
    • Erkhan D, Patel S, Nuzzo M et al Management of the controversial aspects of antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology (Oxford) 47, iii23-iii27 (2008).
    • (2008) Rheumatology (Oxford) , vol.47
    • Erkhan, D.1    Patel, S.2    Nuzzo, M.3
  • 137
    • 0042065114 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies
    • • This study 158 transfers of 296 embryos showed that use of heparin and aspirin did not improve pregnancy implantation rates for women with APS or who were antinuclear antibody positive
    • Stern C, Chamley L, Norris H, Hale L, Baker HW. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil. Steril. 80(2), 376-383 (2003). • This study (158 transfers of 296 embryos) showed that use of heparin and aspirin did not improve pregnancy implantation rates for women with APS or who were antinuclear antibody positive.
    • (2003) Fertil. Steril. , vol.80 , Issue.2 , pp. 376-383
    • Stern, C.1    Chamley, L.2    Norris, H.3    Hale, L.4    Baker, H.W.5
  • 138
    • 0034045163 scopus 로고    scopus 로고
    • Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome
    • Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum. 43(3), 550-556 (2000).
    • (2000) Arthritis Rheum. , vol.43 , Issue.3 , pp. 550-556
    • Guballa, N.1    Sammaritano, L.2    Schwartzman, S.3    Buyon, J.4    Lockshin, M.D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.